ICYMI: Experimental Treatment for Duchenne Muscular Dystrophy Shows Potential in Early Trial
According to a story from globenewswire.com, the biotechnology company Wave Life Sciences Ltd. recently announced that the tolerability and safety data from its Phase 1 clinical trial of its investigational therapy…